Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Genfit stock in Canada | $3.84

Own Genfit shares in just a few minutes.

Genfit is a biotechnology business based in the US. Genfit stocks (GNFT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.8 – a decrease of 0.52% over the previous week. Genfit employs 130 staff and has a trailing 12-month revenue of around $7.8 million.

How to buy Genfit stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GNFT in this case.
  5. Research Genfit stocks. The platform should provide the latest information available.
  6. Buy your Genfit stocks. It's that simple.

Is it a good time to buy Genfit stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Genfit's stock price?

Since the stock market crash in March caused by coronavirus, Genfit's stock price has had significant negative movement.

Its last market close was $3.84, which is 78.50% down on its pre-crash value of $17.86 and 153.39% down on the lowest point reached during the March crash when the stocks fell as low as $9.73.

If you had bought $1,000 worth of Genfit stocks at the start of February 2020, those stocks would have been worth $868.19 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $219.19.

Genfit stock price

Use our graph to track the performance of GNFT stocks over time.

Genfit stocks at a glance

Information last updated 2021-09-19.
Latest market close$3.84
52-week range$3.5 - $6.15
50-day moving average $3.8594
200-day moving average $4.1359
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.065

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.
An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until September 30, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Genfit price performance over time

Historical closes compared with the last close of $3.84

1 week (2021-09-17) -0.52%
1 month (2021-08-25) 3.78%
3 months (2021-06-25) -1.59%
6 months (2021-03-25) -17.60%
1 year (2020-09-25) -8.35%
2 years (2019-09-25) -76.73%

Genfit financials

Revenue TTM USD$7.8 million
Gross profit TTM USD$7.8 million
Return on assets TTM -19.06%
Return on equity TTM -298.13%
Profit margin 0%
Book value $0.952
Market capitalisation USD$178.4 million

TTM: trailing 12 months

How to short and sell Genfit stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "GNFT.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 9,199 Genfit stocks held short by investors – that's known as Genfit's "short interest". This figure is 2% down from 9,385 last month.

There are a few different ways that this level of interest in shorting Genfit stocks can be evaluated.

Genfit's "short interest ratio" (SIR)

Genfit's "short interest ratio" (SIR) is the quantity of Genfit stocks currently shorted divided by the average quantity of Genfit stocks traded daily (recently around 8760.9523809524). Genfit's SIR currently stands at 1.05. In other words for every 100,000 Genfit stocks traded daily on the market, roughly 1050 stocks are currently held short.

However Genfit's short interest can also be evaluated against the total number of Genfit stocks, or, against the total number of tradable Genfit stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genfit's short interest could be expressed as 0% of the outstanding stocks (for every 100,000 Genfit stocks in existence, roughly 0 stocks are currently held short) or 0.0002% of the tradable stocks (for every 100,000 tradable Genfit stocks, roughly 0 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Genfit.

Find out more about how you can short Genfit stock.

Genfit stock dividends

We're not expecting Genfit to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Genfit stock price volatility

Over the last 12 months, Genfit's stocks have ranged in value from as little as $3.5 up to $6.15. A popular way to gauge a stock's volatility is its "beta".

GNFT.US volatility(beta: 1.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genfit's is 1.1357. This would suggest that Genfit's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Genfit overview

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site